Welcome to our dedicated page for Global Medical news (Ticker: GMRE), a resource for investors and traders seeking the latest updates and insights on Global Medical stock.
Global Medical REIT Inc. (GMRE) provides essential healthcare infrastructure through its portfolio of specialized medical facilities. This news hub offers investors and industry professionals centralized access to official announcements and market developments.
Track critical updates including property acquisitions, lease agreements with healthcare providers, and financial performance reports. Our curated collection ensures timely access to strategic partnerships, portfolio expansions, and operational milestones that shape this healthcare REIT's trajectory.
All content undergoes strict verification to maintain accuracy and relevance. Users benefit from comprehensive coverage of GMRE's unique position in medical real estate, including its focus on triple-net lease structures and secondary market specialization.
Bookmark this page for efficient monitoring of GMRE's evolving role in healthcare property markets. Combine regular visits with professional financial analysis when making informed decisions about this niche REIT investment.
Global Medical REIT (NYSE: GMRE), a net-lease medical REIT specializing in healthcare facility acquisitions, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results after market close on Wednesday, May 7, 2025, followed by a conference call on Thursday, May 8, 2025, at 9:00 a.m. Eastern Time.
The conference call will feature Chairman, President, and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the webcast through the company's investor information website. A replay will be available from May 8, 2025, through May 22, 2025, with domestic dial-in number 1-844-512-2921 and international dial-in 1-412-317-6671 (passcode: 13752203).
Global Medical REIT (NYSE: GMRE) reported its Q4 and full-year 2024 financial results, highlighting significant portfolio expansion and strategic partnerships. The company acquired $80.3 million of single-tenant triple-net medical properties at an 8.0% cap rate and entered into a joint venture with Heitman.
Key Q4 2024 metrics include net income of $1.4 million ($0.02 per diluted share), FFO of $11.1 million ($0.15 per share), and AFFO of $15.8 million ($0.22 per share). Portfolio leased occupancy stood at 96.4% with annualized base rent of $110 million.
Notable developments include: entering a purchase agreement for a $69.6 million five-property portfolio at a 9.0% cap rate; completing seven dispositions generating $60.7 million in gross proceeds; and establishing a joint venture with Heitman, which manages over $48 billion in assets. The company provided 2025 AFFO guidance of $0.89-$0.93 per share and announced a Q1 2025 dividend of $0.21 per share.
Global Medical REIT (NYSE: GMRE), a net-lease medical REIT specializing in healthcare facilities, has scheduled its fourth quarter and year-end 2024 financial results announcement. The company will release its results after market close on Thursday, February 27, 2025, followed by a conference call on Friday, February 28, 2025, at 9:00 a.m. Eastern Time.
The conference call will feature Chairman, President, and CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Investors can access the webcast through the company's investor information website. A replay will be available from 12:00 p.m. Eastern Time on February 28 until March 14, 2025.
Global Medical REIT (NYSE: GMRE), a net-lease medical real estate investment trust, has announced the availability of information regarding the federal income tax treatment of its 2024 dividends for both common and preferred stock. The information has been posted on the company's investor relations website.
The company advises stockholders to carefully review their Forms 1099 and other 2024 tax statements from their brokerage firms to ensure consistency with the posted information. GMRE also recommends that shareholders consult with professional tax advisors regarding their individual tax situations.
Global Medical REIT (NYSE: GMRE) announced a CEO succession plan, with Jeffrey Busch transitioning from his CEO position by June 30, 2025, or earlier if a successor is appointed. Busch, who has led GMRE since 2014, will remain on the Board as non-executive Chairman and intends to stand for re-election at the 2025 annual meeting.
Under Busch's leadership, GMRE has grown its portfolio to over 4.8 million square feet leased to premier healthcare providers. The Board's Nominating and Corporate Governance Committee will conduct a comprehensive search for a new CEO with assistance from an executive search firm. Additionally, Lori Wittman has been appointed as Lead Independent Director effective January 1, 2025.
Global Medical REIT (NYSE: GMRE) has announced its 2024 fourth quarter dividend distributions. The company will pay a common dividend of $0.21 per share/unit on January 8, 2025, to stockholders of record as of December 20, 2024. Additionally, GMRE declared a Series A Preferred Stock dividend of $0.46875 per share, payable on January 31, 2025, to preferred stockholders of record as of January 15, 2025, covering the period from October 31, 2024, through January 30, 2025.
Global Medical REIT (NYSE: GMRE) reported third quarter 2024 financial results, highlighting $80.3 million in completed acquisitions of single-tenant triple-net medical real estate. Key metrics include net income of $1.8 million ($0.03 per diluted share), FFO of $13.7 million ($0.19 per share), and AFFO of $15.3 million ($0.22 per share). The company's portfolio maintained 96.1% occupancy with annualized base rent of $107.8 million. Notable developments include the acquisition of a 15-property portfolio and entering into a purchase agreement for a $70 million five-property portfolio at a 9.0% cap rate. The company also completed strategic dispositions and addressed Steward Health Care's bankruptcy through a new lease agreement with CHRISTUS Health.
Global Medical REIT Inc. (NYSE: GMRE), a net-lease medical REIT, has announced its schedule for the release of its third quarter 2024 financial results. The company plans to release the results after market close on Wednesday, November 6, 2024, followed by a conference call on Thursday, November 7, 2024, at 9:00 a.m. Eastern Time.
The conference call will be hosted by key executives including Jeffrey Busch (Chairman, President, and CEO), Robert Kiernan (CFO), and Alfonzo Leon (CIO). Participants can access the call via a live webcast on the company's investor information website or through dial-in numbers provided for both U.S. and international callers.
A replay of the call will be available from approximately 12:00 p.m. Eastern Time on November 7, 2024, through November 21, 2024. GMRE specializes in acquiring healthcare facilities and leasing them to physician groups and healthcare systems.
Global Medical REIT Inc. (NYSE: GMRE) has announced a new 15-year, triple-net lease with CHRISTUS Health for its healthcare facility in Beaumont, Texas. This development follows the Chapter 11 bankruptcy filing of the previous tenant, Steward Health Care, on May 6, 2024. Steward has requested its lease be rejected by September 15, 2024, pending court approval.
CHRISTUS plans to use the facility for services including robotic surgery, orthopedic care, and emergency services. GMRE's CEO, Jeffrey M. Busch, expressed excitement about the new partnership, highlighting the facility's quality and marketability. Paul Generale, EVP and Chief Strategy Officer of CHRISTUS, stated that the Beaumont facility will be important in expanding healthcare services in Southeast Texas.
Global Medical REIT Inc. (NYSE: GMRE), a net-lease medical REIT, has announced its 2024 third quarter dividends. The Board of Directors declared a common stock dividend of $0.21 per share, payable on October 8, 2024, to stockholders of record as of September 20, 2024. Additionally, a quarterly cash dividend of $0.46875 per share was declared on its Series A Cumulative Redeemable Preferred Stock, to be paid on October 31, 2024, to preferred stockholders of record as of October 15, 2024. This preferred dividend covers the period from July 31, 2024, through October 30, 2024.
